Embark Veterinary Inc., an Austin, Texas-based provider of a dog DNA test to improve dog health and wellness, launched with over $1.8m in seed funding.
Backers included Slow Ventures and the Aspiration Growth Fund.
Led by Ryan Boyko, CEO, and Dr. Adam Boyko, Chief Science Officer and Assistant Professor of Biomedical Sciences at the Cornell veterinary college, the company is launching The Embark Dog DNA Test, which tracks over 200,000 genetic markers, offering ancestry analysis as well as key insights into genetic disease risk and heritable traits.
The test has been launched in partnership with the Cornell University College of Veterinary Medicine,
The test retails at $199.
FinSMEs
31/05/2016